| COVID-19 |
1 |
1 |
| Otolaryngology |
0 |
0.57 |
| Impairment |
0 |
0.99 |
| Cerebrovascular Accident |
0 |
0.48 |
| Brain |
0 |
0.39 |
| Thromboembolism |
0 |
0.38 |
| Dentistry and Oral Health |
0 |
0.29 |
| Blood |
0 |
0.26 |
| Colorado |
0 |
0.26 |
| Fatigue |
0 |
0.26 |
| Neuroradiology |
0 |
0.26 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.26 |
| Headache |
0 |
0.24 |
| Cardiovascular Risk Management |
0 |
0.21 |
| Lipids Management |
0 |
0.19 |
| Atherosclerosis |
0 |
0.13 |
| California |
0 |
0.13 |
| Cerebrovascular Disease |
0 |
0.13 |
| Critical Illness |
0 |
0.13 |
| Dysgeusia |
0 |
0.13 |
| Grant |
0 |
0.13 |
| Insomnia |
0 |
0.13 |
| Memory |
0 |
0.13 |
| Pandemic |
0 |
0.13 |
| Perfusion Imaging |
0 |
0.13 |
| Phantosmia |
0 |
0.13 |
| Tinnitus |
0 |
0.13 |
| Viral Load |
0 |
0.13 |
| Cardiovascular Imaging |
0 |
0.12 |
| Depression |
0 |
0.12 |
| HIV Infection |
0 |
0.12 |
| Sleep Disorders |
0 |
0.12 |
| Vasculitis |
0 |
0.12 |